Table 1 Baseline characteristics according to randomized left atrial appendage closure
Variable | Not closed (n = 86) | Closed (n = 101) |  |
|---|---|---|---|
Age – years | 69.3 ± 8.8 | 67.6 ± 9.6 |  |
Men - n (%) | 75 (87.2) | 84 (83.2) | Â |
Clinical characteristics | |||
 Congestive heart failure - n (%) | 15 (17.9) | 16 (15.8) |  |
 Atrial fibrillation - n (%) | 12 (12.8) | 18 (16.8) |  |
 Diabetes - n (%) | 19 (22.1) | 31 (30.7) |  |
 Hypertension - n (%) | 60 (69.8) | 75 (74.3) |  |
 CHADS-VASc – unit | 2.9 ± 1.4 | 2.9 ± 1.5 |  |
 Prior stroke - n (%) | 15 (17.4) | 11 (10.9) |  |
 Chronic kidney diseasea - n (%) | 14 (16.3) | 15 (14.9) |  |
Medicine | |||
 ASA - n (%) | 69 (80.2) | 75 (74.3) |  |
 Clopidogrel - n (%) | 14 (16.3) | 19 (18.8) |  |
 OAC | |||
  VKA - n (%) | 26 (30.2) | 36 (35.6) |  |
  NOAC - n (%) | 2 (2.2) | 2 (2.0) |  |
 Beta-blocker - n (%) | 47 (54.7) | 61 (60.4) |  |
 Verapamil - n (%) | 4 (4.5) | 2 (2.0) |  |
 Calcium-blocker - n (%) | 19 (21.3) | 34 (33.7) |  |
 Digoxin - n (%) | 5 (5.6) | 3 (3.0) |  |
 Renin-angiotensin system blocker - n (%) | 40 (46.5) | 54 (53.5) |  |
 Amiodarone - n (%) | 23 (26.7) | 18 (17.8) |  |
 Statin - n (%) | 74 (86.0) | 81 (80.2) |  |
Procedural characteristics | |||
Surgery type | |||
 AVR only - n (%) | 17 (19.1) | 17 (16.8) |  |
 AVR with CABG - n (%) | 20 (22.5) | 22 (21.8) |  |
 AVR with aortic surgery - n (%) | 1 (1.1) | 1 (1.0) |  |
 AVR with MVR - n (%) | 0 (0) | 2 (2.0) |  |
 Aortic surgery only - n (%) | 1 (1.1) | 0 (0) |  |
 CABG only - n (%) | 40 (46.5) | 50 (49.5) |  |
 CABG with MVR - n (%) | 2 (2.3) | 2 (2.0) |  |
 MVR only - n (%) | 4 (4.5) | 7 (6.9) |  |
 Tricuspid surgery only - n (%) | 1 (1.2) | 0 (0) |  |
Perioperative atrial fibrillation - n (%) | 52 (60.5) | 50 (50.0) | Â |